Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Carousell becomes Singapore’s newest unicorn, Acorns names former Amazon executive as president, and Anghami partners with Amazon Prime
Online Marketplace Carousell Is Singapore’s Newest Unicorn
Online classifieds marketplace Carousell Pte became Singapore’s latest tech unicorn, raising funds at a $1.1 billion valuation as Southeast Asia’s e-commerce startups benefit from the pandemic and related lockdowns, according to Bloomberg.
The company got $100 million in a round led by South Korean private equity firm STIC Investments.
Carousell has weighed a U.S. listing via a merger with a blank-check company, people with knowledge of the matter said in June.READ
Acorns Names Amazon Alum David Hijirida as President Ahead of IPO
Acorns Grow Inc. hired former Amazon.com Inc. executive David Hijirida as its president, as the savings and investing startup prepares to go public by merging with a blank-check company.
On May 27, Acorns entered into a definitive agreement to combine with Pioneer Merger Corp. (NASDAQ:PACX).READ
Amazon Prime and Anghami Collaborate in Saudi Arabia and United Arab Emirates with Anghami Plus
Amazon and Anghami have today announced that Amazon Prime members in Saudi Arabia and the UAE can enjoy an exclusive six-months free offer on Anghami Plus, Anghami’s premium paid tier, with their Prime membership.
Prime members in Saudi Arabia and the UAE will receive a free six-month subscription to Anghami Plus, followed by 50% off the subscription fee for the next six months.
On March 3, Anghami entered into a definitive agreement to combine with Vistas Media (NASDAQ:VMAC).READ
SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.
SAB-176 is a novel anti-influenza human immunotherapy designed to address the limitations of current treatments for moderate to severe seasonal influenza.
On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP).READ
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...
Seaport Calibre Materials Acquisition Corp. (Nasdaq: SCMA) announced this afternoon that it is pushing today’s special meeting back until January 31. The SPAC is currently facing a completion deadline of February 1, but is looking to extend its timeline by an additional six months to August 1. Stockholders may elect to redeem their shares for a pro rata...